sgRNA Knock-in Mouse Provides an Alternative Approach for In Vivo Genetic Modification

被引:1
|
作者
Zhang, Lichen [1 ,2 ]
Li, Wushan [1 ,3 ]
Liu, Zhuangzhuang [1 ,3 ]
Liu, Yang [1 ,2 ]
Liu, Zhilong [1 ,2 ]
Gu, Yanrong [1 ,2 ]
He, Le [1 ,2 ]
Zhou, Binhui [1 ,3 ]
Li, Tianhan [1 ,2 ]
Chao, Tianzhu [1 ,3 ]
Liang, Yinming [1 ,2 ,3 ]
Lu, Liaoxun [1 ,2 ,3 ]
机构
[1] Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Lab Genet Regulators Immune Syst, Sch Lab Med, Xinxiang, Henan, Peoples R China
[2] Xinxiang Med Univ, Henan Key Lab Immunol & Targeted Therapy, Xinxiang, Henan, Peoples R China
[3] Xinxiang Med Univ, Inst Psychiat & Neurosci, Xinxiang, Henan, Peoples R China
关键词
sgRNA knock-in; mouse model; genetic modification; Gfi1; neutrophil; MUTATION; CELLS; MICE;
D O I
10.3389/fcell.2021.769673
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Functional genomics in a mammalian model such as mice is fundamental for understanding human biology. The CRISPR/Cas9 system dramatically changed the tempo of obtaining genetic mouse models due to high efficiency. However, experimental evidence for the establishment of sgRNA knock-in animals and analyses of their value in functional genomics are still not sufficient, particularly in mammalian models. In this study, we demonstrate that the establishment of sgRNA knock-in mice is feasible, and more importantly, crosses between sgRNA knock-in mice and the Cas9 constitutively expressing mice result in complete deletion of the target gene. Such sgRNA knock-in provides an alternative approach for in vivo genetic modification and can be useful in multiple circumstances, such as maintenance of genetically modified animals, which are difficult to breed as homozygotes, and cross of such mice to diverse genomic backgrounds to obtain genetically modified animals.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Integration of metabolomics and transcriptomics provides insights into enhanced osteogenesis in Ano5Cys360Tyr knock-in mouse model
    Li, Hongyu
    Liu, Sirui
    Miao, Congcong
    Lv, Yan
    Hu, Ying
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [32] An ATF3-CreERT2 Knock-In Mouse for Axotomy-Induced Genetic Editing: Proof of Principle
    Holland, Seth D.
    Ramer, Leanne M.
    McMahon, Stephen B.
    Denk, Franziska
    Ramer, Matt S.
    ENEURO, 2019, 6 (02)
  • [33] An estrogen receptor (ER)α deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo
    Jakacka, M
    Ito, M
    Martinson, F
    Ishikawa, T
    Lee, EJ
    Jameson, JL
    MOLECULAR ENDOCRINOLOGY, 2002, 16 (10) : 2188 - 2201
  • [34] In-vivo free-water imaging and functional connectivity in a knock-in mouse model of DYT1 dystonia
    DeSimone, J. C.
    Febo, M.
    Shukla, P.
    Ofori, E.
    Colon-Perez, L. M.
    Li, Y.
    Vaillancourt, D. E.
    MOVEMENT DISORDERS, 2016, 31 : S543 - S543
  • [35] Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the in vivo Biological Context
    Sarrio, David
    Rojo-Sebastian, Alejandro
    Teijo, Ana
    Perez-Lopez, Maria
    Diaz-Martin, Eva
    Martinez, Lidia
    Morales, Saleta
    Garcia-Sanz, Pablo
    Palacios, Jose
    Moreno-Bueno, Gema
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [36] Characterization of Platelet-Derived Growth Factor-A Expression in Mouse Tissues Using a lacZ Knock-In Approach
    Andrae, Johanna
    Gouveia, Leonor
    He, Liqun
    Betsholtz, Christer
    PLOS ONE, 2014, 9 (08):
  • [37] An estrogen receptor-α knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo
    Sinkevicius, Kerstin W.
    Burdette, Joanna E.
    Woloszyn, Karolina
    Hewitt, Sylvia C.
    Hamilton, Katherine
    Sugg, Sonia L.
    Temple, Karla A.
    Wondisford, Fredric E.
    Korach, Kenneth S.
    Woodruff, Teresa K.
    Greene, Geoffrey L.
    ENDOCRINOLOGY, 2008, 149 (06) : 2970 - 2979
  • [38] Humanized knock-in mouse models for evaluating in vivo efficacy of immune-oncology drugs targeting stimulatory immune checkpoint molecules
    Gan, T.
    Xiang, J.
    Guo, C.
    Guo, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 420 - 420
  • [39] Humanized knock-in mouse models for evaluating in vivo efficacy of immune-oncology drugs targeting inhibitory immune checkpoint molecules
    Zhang, Baozhu
    Guo, Chaoshe
    Shen, Yuelei
    Guo, Yanan
    CANCER RESEARCH, 2018, 78 (13)
  • [40] A practical method for evaluating the in vivo efficacy of EVA-71 vaccine using a hSCARB2 knock-in mouse model
    Wu, Yong
    Qu, Zhe
    Xiong, Rui
    Yang, Yanwei
    Liu, Susu
    Nie, Jianhui
    Liang, Chunnan
    Huang, Weijin
    Wang, Youchun
    Fan, Changfa
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1180 - 1190